Epigral Q1 Profit Drops 38%

Epigral Limited, an integrated chemical manufacturer, reported a 37.9% decline in net profit to Rs 99.7 crore for the first quarter of FY27.

Despite this, the company's revenue from operations increased by 16.3% to Rs 705.4 crore.

The decline in profit was attributed to severe macroeconomic volatility and geopolitical tensions in West Asia, which caused fluctuations in raw material and finished goods prices, as well as elevated freight costs and shipment delays.

However, the company's EBITDA rose by 9.7% to Rs 179.2 crore.

The board approved the company's entry into the epoxy resin and formulations business, with a planned production capacity of 1,25,000 tonnes per annum.

This expansion is expected to cater to demand from various industries such as construction, renewable energy, automotive, electronics, infrastructure, marine, aerospace, and semiconductors.

The company plans to commission both the epoxy resin facility and the Multi-Purpose Plant during the second half of FY28, with an estimated capital expenditure of Rs 600 crore.